Cargando…

Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer

Despite remarkable recent progress in treating solid cancers, especially the success of immunomodulatory antibody therapies for numerous different cancer types, it remains the case that many patients fail to respond to treatment. It is therefore of immense importance to identify biomarkers predictin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wistuba-Hamprecht, Kilian, Gouttefangeas, Cécile, Weide, Benjamin, Pawelec, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296133/ https://www.ncbi.nlm.nih.gov/pubmed/32582215 http://dx.doi.org/10.3389/fimmu.2020.01152

Ejemplares similares

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
por: Lazar, Katrin, et al.
Publicado: (2021)

Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II
por: Wistuba-Hamprecht, Kilian, et al.
Publicado: (2015)

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
por: Gaißler, Andrea, et al.
Publicado: (2022)

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
por: Gaißler, Andrea, et al.
Publicado: (2023)

Genetic Influence on the Peripheral Differentiation Signature of Vδ2+ γδ and CD4+ αβ T Cells in Adults
por: Beucke, Nicola, et al.
Publicado: (2021)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
por: Bochem, Jonas, et al.
Publicado: (2019)

Age-associated alterations in γδ T-cells are present predominantly in individuals infected with Cytomegalovirus
por: Wistuba-Hamprecht, Kilian, et al.
Publicado: (2013)

The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
por: Simon, Bianca, et al.
Publicado: (2018)

The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
por: Gouttefangeas, Cécile, et al.
Publicado: (2023)

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
por: Picard, Emilie, et al.
Publicado: (2020)

Monocytic myeloid-derived suppressor cells in advanced melanoma patients: Indirect impact on prognosis through inhibition of tumor-specific T-cell responses?
por: Martens, Alexander, et al.
Publicado: (2014)

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
por: Chen, Rui-Lian, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
por: Pawelec, Graham, et al.
Publicado: (2019)

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy
por: Bochem, Jonas, et al.
Publicado: (2021)

An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer
por: Yan, Hongfei, et al.
Publicado: (2021)

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
por: Turiello, Roberta, et al.
Publicado: (2020)

Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodes
por: Maus, Rachel L. G., et al.
Publicado: (2022)

Editorial: Frontiers’ Research Topic “Cancer Vaccines: Time to Think Differently!”
por: McArdle, Stephanie E. B., et al.
Publicado: (2021)

A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma
por: Xue, Ya-Nan, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

A gene expression signature associated with survival in metastatic melanoma
por: Mandruzzato, Susanna, et al.
Publicado: (2006)

Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma
por: Yakkala, Chakradhar, et al.
Publicado: (2021)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Is There a Positive Side to T Cell Exhaustion?
por: Pawelec, Graham
Publicado: (2019)

Commentary: A novel signature of 23 immunity related gene pairs is prognostic of cutaneous melanoma
por: Shen, Ruihuan, et al.
Publicado: (2023)

Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
por: Queirolo, Paola, et al.
Publicado: (2017)

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
por: Yang, Jingrun, et al.
Publicado: (2022)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
por: Elia, Angela Rita, et al.
Publicado: (2018)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
por: Queirolo, Paola, et al.
Publicado: (2018)

Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma
por: Lardone, Ricardo D., et al.
Publicado: (2016)

Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report
por: Mari, Roxane, et al.
Publicado: (2022)

Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
por: Benboubker, Valentin, et al.
Publicado: (2022)

Modeling flow cytometry data for cancer vaccine immune monitoring
por: Frelinger, Jacob, et al.
Publicado: (2010)

An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma
por: Yan, Junya, et al.
Publicado: (2022)

Editorial: Immunology of Aging
por: Pawelec, Graham, et al.
Publicado: (2019)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients
por: Hu, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lli6mou8n57269sdfljoumve3r